JOYof ART – an Intervention Study

Overview

Music, dance and visual arts are suggested to support health and well-being of older people. Intervention studies, however, are scarce. JOY of ART study investigates the effects of multicomponent art intervention among older people and ther family caregivers.

Full Title of Study: “JOY of ART – an Intervention Study for Older Adults and Their Family Caregivers”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 2018

Detailed Description

JOY of ART study investigates the effects of group based intervention including music, dance and visual arts. Art sessions are provided once a week in three months period each session takes 60 minutes. Eligible participants are recruited from the City of Kuopio, Finland, total 60 dyads, 30 to intervention group and 30 to control group. Health, physical performance and quality of life assessments are conducted at the baseline and in the end of the intervention. In addition, participants are contacted by phone and interviewed six months after the intervention has completed. For family caregivers qualitative interviews are conducted at the baseline and in the end of the study.

Interventions

  • Other: Art
    • Multicomponent art intervention

Arms, Groups and Cohorts

  • Experimental: Intervention
    • Art groups are held once a week, each with the duration of 60 minutes. They begin with a 45 minute art intervention and conclude with a 15 minute discussion. The art groups include music, dance and visual arts, which is psychologically, socially, and physically activating. Music has the main emphasis in art intervention. The preferences of the subjects are taken into consideration in art intervention. Art intervention is conducted by trained and experienced art pedagogues. Art intervention aims to revive previously learned art-related skills, to learn and enhance new skills, and to improve and intensify physiological, emotional, social, motoric, and cognitive abilities.
  • No Intervention: Control
    • Baseline and follow-up measurements.

Clinical Trial Outcome Measures

Primary Measures

  • Mental Well-being assessed using the Warwick-Edinburgh Mental Well-being scale (WEMWBS)
    • Time Frame: Change in Mental Well-being from baseline until three month follow-up
    • The Warwick-Edinburgh Mental Well-being scale (WEMWBS)

Secondary Measures

  • Mobility and Balance assessed using Timed up & Go (TUG)
    • Time Frame: Change in Mobility and Balance from baseline until three month follow-up
    • Timed up & Go (TUG)
  • Physical Performance assessed using Short Physical Performance Battery (SPPB)
    • Time Frame: Change in Physical Performance from baseline until three month follow-up
    • Short Physical Performance Battery (SPPB)
  • Quality of Life assessed using EQ- 5D-5L
    • Time Frame: Change in Quality of Life from baseline until three month follow-up
    • EQ- 5D-5L
  • Psychological Distress assessed using General Health Questionnaire (GHQ 12)
    • Time Frame: Change in Psychological Distress from baseline until three month follow-up
    • General Health Questionnaire (GHQ 12)
  • Use of Social and Health Care Services assessed using Questionnaire
    • Time Frame: Change in use of Social and Health Care Service use from baseline until three month follow-up
    • Questionnaire on Social and Health Care service use

Participating in This Clinical Trial

Inclusion Criteria

  • 65+ age, family caregiving dyad, ability to walk independently or assisted, home dwelling

Exclusion Criteria

  • severe dementia, severe aphasia

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Eastern Finland
  • Collaborator
    • Kuopio Conservatory
  • Provider of Information About this Clinical Study
    • Principal Investigator: Tarja Välimäki, Principal Investigator – University of Eastern Finland
  • Overall Contact(s)
    • Tarja Välimäki, PhD, +358403552267, tarja.valimaki@uef.fi

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.